Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for sleep quality in mild traumatic brain injury
IRCT20220504054738N1Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in traumatic brain injury (TBI), sponsored by Kashan University of Medical Sciences. Primary endpoint: Sleep quality. Started Mar 2023; status: completed.
02
Drugs
melatonin
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20220504054738N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220504054738N1.